Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study.
Imai K, Takai K, Nishigaki Y, Shimizu S, Naiki T, Hayashi H, Uematsu T, Sugihara J, Tomita E, Shimizu M, Nagaki M, Moriwaki H. Imai K, et al. Among authors: nagaki m. Hepatol Res. 2010 Apr;40(4):376-82. doi: 10.1111/j.1872-034X.2009.00616.x. Epub 2010 Mar 4. Hepatol Res. 2010. PMID: 20236359
Prospective study on early virologic response to treatment with interferon alpha-2b plus ribavirin in patients with chronic hepatitis C genotype 1b.
Nagaki M, Imose M, Naiki T, Kimura K, Hayashi H, Shimizu M, Ohnishi H, Tomita E, Sugihara J, Amano K, Sakai T, Kojima T, Katsumura N, Kondo Y, Fujimoto M, Moriwaki H; GH Study Group. Nagaki M, et al. Hepatol Res. 2005 Dec;33(4):285-91. doi: 10.1016/j.hepres.2005.08.010. Epub 2005 Nov 18. Hepatol Res. 2005. PMID: 16298546
Hepatoprotection against oxidative damage.
Nagaki M, Moriwaki H. Nagaki M, et al. Hepatol Res. 2005 May;32(1):9-11. doi: 10.1016/j.hepres.2005.03.003. Hepatol Res. 2005. PMID: 15886054 No abstract available.
128 results